MYCN and neuroblastoma: While THZ1 appears to preferentially affect genes controlled by super-enhancers in neuroblastoma, MYCN-dependent genes in particular [44,72], there is evidence to indicate that the off-target inhibition of CDK12 and CDK13 rather than of CDK7 is responsible for the transcriptional effects of THZ1 [72].